ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,152.58
      0.42%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Acorda Therapeutics Inc (ACOR)

      7. Acorda Therapeutics Inc (ACOR) News

      ACOR

      Acorda Therapeutics (ACOR)

      Acorda Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ACOR
      DateTimeSourceHeadlineSymbolCompany
      04/15/20245:03PMBusiness WireAcorda Therapeutics Announces Delisting from NasdaqNASDAQ:ACORAcorda Therapeutics Inc
      04/03/20245:30PMBusiness WireAcorda Therapeutics Announces Nasdaq Delisting NotificationNASDAQ:ACORAcorda Therapeutics Inc
      04/01/20246:35PMBusiness WireAcorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase AgreementNASDAQ:ACORAcorda Therapeutics Inc
      04/01/20244:01PMBusiness WireAcorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024NASDAQ:ACORAcorda Therapeutics Inc
      03/25/20244:01PMBusiness WireAcorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024NASDAQ:ACORAcorda Therapeutics Inc
      01/11/20248:33AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACORAcorda Therapeutics Inc
      01/11/20248:01AMBusiness WireAcorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025NASDAQ:ACORAcorda Therapeutics Inc
      12/01/20234:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACORAcorda Therapeutics Inc
      11/13/20234:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACORAcorda Therapeutics Inc
      11/13/20234:01PMBusiness WireAcorda Therapeutics Reports Third Quarter 2023 Financial ResultsNASDAQ:ACORAcorda Therapeutics Inc
      11/06/20234:01PMBusiness WireAcorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023NASDAQ:ACORAcorda Therapeutics Inc
      11/06/20238:00AMBusiness WireAcorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA®NASDAQ:ACORAcorda Therapeutics Inc
      08/08/20234:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACORAcorda Therapeutics Inc
      08/08/20234:01PMBusiness WireAcorda Therapeutics Reports Second Quarter 2023 Financial ResultsNASDAQ:ACORAcorda Therapeutics Inc
      08/02/20238:00AMBusiness WireAcorda Therapeutics Announces Launch of New INBRIJA® Campaign: “For The Fighters™”NASDAQ:ACORAcorda Therapeutics Inc
      08/01/20238:00AMBusiness WireAcorda Second Quarter 2023 Update: Webcast/Conference Call Scheduled for August 8, 2023NASDAQ:ACORAcorda Therapeutics Inc
      06/28/20235:08PMBusiness WireTom Burns Elected to the Acorda Therapeutics Board of DirectorsNASDAQ:ACORAcorda Therapeutics Inc
      06/26/20234:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACORAcorda Therapeutics Inc
      06/26/20238:23AMBusiness WireAcorda Therapeutics Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:ACORAcorda Therapeutics Inc
      06/26/20238:00AMBusiness WireAcorda Therapeutics Regains Compliance with Nadaq Minimum Bid Price RequirementNASDAQ:ACORAcorda Therapeutics Inc
      06/23/20235:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACORAcorda Therapeutics Inc
      06/23/20235:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACORAcorda Therapeutics Inc
      06/23/20235:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACORAcorda Therapeutics Inc
      06/23/20235:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACORAcorda Therapeutics Inc
      06/02/20234:29PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACORAcorda Therapeutics Inc
      06/02/20234:01PMBusiness WireAcorda Therapeutics Announces Completion of 1-for-20 Reverse Stock SplitNASDAQ:ACORAcorda Therapeutics Inc
      06/01/20235:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACORAcorda Therapeutics Inc
      05/31/20235:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACORAcorda Therapeutics Inc
      05/31/20234:01PMBusiness WireAcorda Therapeutics to Conduct 1-for-20 Reverse Stock SplitNASDAQ:ACORAcorda Therapeutics Inc
      05/30/20238:00AMBusiness WireAcorda Therapeutics CEO Ron Cohen, M.D., to Hold Virtual Company Presentation and Q&ANASDAQ:ACORAcorda Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ACOR